Overall, these studies propose that epimorphin activates αV integrin receptors and the transcription factors C/EBPβ and KLF4 which can be a positive regulator of endogenous epithelial differentiation in ovarian cancer cells. This evidence concerns the gene CEBPB and ovarian cancer.